|
USP21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.901200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.615390E-01 |
| Normal-vs-Stage2 |
8.681600E-01 |
| Normal-vs-Stage3 |
8.803400E-01 |
| Normal-vs-Stage4 |
7.761400E-01 |
| Stage1-vs-Stage2 |
5.133800E-01 |
| Stage1-vs-Stage3 |
3.902800E-01 |
| Stage1-vs-Stage4 |
6.661200E-01 |
| Stage2-vs-Stage3 |
8.144800E-01 |
| Stage2-vs-Stage4 |
9.532000E-01 |
| Stage3-vs-Stage4 |
7.540400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.086400E-01 |
| Normal-vs-AfricanAmerican |
3.364600E-01 |
| Normal-vs-Asian |
5.217700E-02 |
| Caucasian-vs-AfricanAmerican |
4.373000E-01 |
| Caucasian-vs-Asian |
2.620600E-01 |
| AfricanAmerican-vs-Asian |
3.114000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.179000E-01 |
| Normal-vs-Female |
3.507600E-01 |
| Male-vs-Female |
6.600400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.392200E-01 |
| Normal-vs-Extreme_Weight |
1.416010E-01 |
| Normal-vs-Obese |
9.447400E-01 |
| Normal-vs-Extreme_Obese |
6.200400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.370400E-01 |
| Normal_Weight-vs-Obese |
5.278000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.591200E-01 |
| Extreme_Weight-vs-Obese |
2.134200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.293000E-01 |
| Obese-vs-Extreme_Obese |
6.813800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.071400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.892400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.238600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.921250E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.651600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.289200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.277300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.093600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.578300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.148000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.050800E-01 |
| Normal-VS-Type2 PRCC |
1.542960E-03 |
| Normal-VS-KIRP CIMP |
8.974600E-01 |
| Normal-VS-Unclassified PRCC |
4.288800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.01319999999505E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.843000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.358600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.090400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.101400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.265600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.608400E-02 |
| Normal-vs-N1 |
3.549000E-01 |
| Normal-vs-N2 |
9.352400E-01 |
| N0-vs-N1 |
5.259600E-02 |
| N0-vs-N2 |
3.523400E-01 |
| N1-vs-N2 |
7.205600E-01 |
|
|
